Stock Information
Lantheus Holdings Inc (LNTH)
Ticker Symbol: LNTH
Exchange: NASDAQ
Sector: Health Care
Market Cap: $6,573.76 mil
Piotroski score: 8
PE Ratio: 23.68
EPS (TTM): 4.13
Revenue (TTM): $23.05 M
Dividend Yield: N/A
ROE: 23.27%
Latest News
-
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
Mon, Sep 28, 2026 12:00 PM
-
Lantheus Holdings Announces First Patient Dosed In SPARROW NCT07831824, Phase 2/3 Registrational Trial Evaluating LNTH-2401
Mon, Sep 28, 2026 8:04 AM
-
Lantheus Holdings (LNTH) Could Be 7% Undervalued On BRAVNETSA Approval
Sat, Sep 26, 2026 6:10 PM
-
Lantheus Holdings (LNTH) Stock May Be 14% Undervalued On FDA Approval
Sat, Sep 26, 2026 2:08 AM
-
Strong Earnings, FDA Approval, and Takeover Interest Drive Lantheus Holdings’ (LNTH) Rally
Wed, Sep 23, 2026 2:14 PM
-
3 Reasons LNTH is Risky and 1 Stock to Buy Instead
Wed, Sep 23, 2026 1:57 PM
-
Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs
Tue, Sep 22, 2026 12:00 PM
Key Financials
Financial data not available
